Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ ZENODOarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Article . 2025
License: CC BY
Data sources: ZENODO
ZENODO
Article . 2025
License: CC BY
Data sources: Datacite
ZENODO
Article . 2025
License: CC BY
Data sources: Datacite
versions View all 2 versions
addClaim

Tele-oncology and the Future of Cancer Care Delivery: A Review of Emerging Models, Rural Applications, and Pharmaceutical Integration

Authors: Dr. Omid Modiramani;

Tele-oncology and the Future of Cancer Care Delivery: A Review of Emerging Models, Rural Applications, and Pharmaceutical Integration

Abstract

Abstract Importance: Teleoncology—the use of telemedicine technologies in oncology—has emerged as a critical tool in addressing cancer care disparities, particularly among rural, underserved, and resource-limited populations. Despite growing adoption, comprehensive synthesis of its implementation, barriers, and future directions remains limited. Objective: To review the historical evolution, core applications, challenges, and future directions of teleoncology, with emphasis on rural deployment, pharmaceutical industry integration, and implications for equity-based cancer care delivery. Evidence Review: A narrative review was conducted of literature published between January 2005 and March 2024 using PubMed, Scopus, WHO reports, ASCO resources, and policy documents from oncology organizations and government health agencies. Included sources comprised peer-reviewed studies, white papers, program evaluations, and regulatory frameworks. Key themes were synthesized under domains including access to care, remote treatment monitoring, decentralized trials, patient experience, infrastructure, and stakeholder collaboration. Findings: Teleoncology has evolved from early second-opinion consults to comprehensive models including remote diagnosis, virtual tumor boards, remote chemotherapy supervision, and digital navigation tools. Rural implementation in the United States has shown significant benefits including reduced travel burden, improved time-to-treatment, and non-inferior survival rates. Globally, countries such as Australia, India, and Kenya have adopted teleoncology to extend services to remote areas. Major pharmaceutical companies now support teleoncology-enabled decentralized clinical trials, AI-powered symptom tracking, and real-world evidence generation. Key barriers to implementation include infrastructure deficits, inconsistent reimbursement, regulatory misalignment, digital literacy gaps, and ethical concerns about data use. Emerging hybrid care models, equity-centered platform design, and global licensing frameworks are shaping the future landscape.

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average
Green
Related to Research communities
Cancer Research